Environmental Toxicology and Chemistry,
Год журнала:
2025,
Номер
44(3), С. 777 - 785
Опубликована: Янв. 6, 2025
Abstract
N-Nitrosamines
are
a
class
of
compounds
that
includes
the
potent
mutagenicity
and
carcinogenicity
many
its
members
is
distributed
widely
throughout
human
environment.
DNA
alkylation
by
their
diazonium
ions
formed
metabolically
acts
as
molecular
initiating
event
(MIE)
links
chemistry
to
mutagenicity.
However,
regiochemistry
for
reacting
with
bases
still
under
debate.
Hence,
density
functional
theory
calculations
involving
SN2
guanine
(Gua)
14
diverse
presented,
results
which
showed
mutagenicity-related
shift
from
GuaN7-
GuaO6-alkylation
proceeds
increasing
complexity
alkylating
agents,
along
greater
proportion
SN1
characteristic
in
transition
states.
“high
oxyphilic”
“low
agents
may
instead
be
“SN1”
“SN2”
species,
respectively.
As
degree
MIE
selectivity
hard−hard
interactions
can
quantified
hard
soft
acids
theory,
quantitative
relationships
were
modeled
between
nucleophilic
index
(ω-)
hydrophobicity
(log
P)
carcinogenic
potency.
Therefore,
mechanistic
link
target
toxicity
bridged
computational
chemistry.
Journal of Pharmaceutical Sciences,
Год журнала:
2022,
Номер
112(5), С. 1287 - 1304
Опубликована: Ноя. 17, 2022
This
article
reports
the
outcome
of
an
in
silico
analysis
more
than
12,000
small
molecule
drugs
and
drug
impurities,
identifying
nitrosatable
structures,
assessing
their
potential
to
form
nitrosamines
under
relevant
conditions
challenges
determine
compound-specific
AIs
based
on
data
available
or
read-across
approaches
for
these
acceptance
by
health
authorities.
Our
indicate
that
presence
pharmaceuticals
is
likely
prevalent
originally
expected.
In
total,
40.4
%
analyzed
APIs
29.6
API
impurities
are
nitrosamine
precursors.
Most
structures
identified
through
our
workflow
could
complex
API-related
nitrosamines,
so-called
substance
related
(NDSRIs),
although
we
also
found
release
well-known
potent
NDMA,
NDEA,
others.
Due
common
structural
motifs
including
secondary
tertiary
amine
moieties,
whole
essential
classes
such
as
beta
blockers
ACE
inhibitors
at
risk.
To
avoid
risk
shortages
even
complete
loss
therapeutic
options,
it
will
be
well-established
ICH
M7
principles
remain
applicable
industry
regulatory
authorities
keep
open
communication
not
only
about
science
but
make
sure
there
a
good
balance
between
benefit
patients.
Regulatory Toxicology and Pharmacology,
Год журнала:
2024,
Номер
150, С. 105640 - 105640
Опубликована: Май 14, 2024
N-Nitrosamine
impurities,
including
nitrosamine
drug
substance-related
impurities
(NDSRIs),
have
challenged
pharmaceutical
industry
and
regulators
alike
affected
the
global
supply
over
past
5
years.
Nitrosamines
are
a
class
of
known
carcinogens,
but
NDSRIs
posed
additional
challenges
as
many
lack
empirical
data
to
establish
acceptable
intake
(AI)
limits.
Read-across
analysis
from
surrogates
has
been
used
identify
AI
limits
in
some
cases;
however,
this
approach
is
limited
by
availability
robustly-tested
matching
structural
features
NDSRIs,
which
usually
contain
diverse
array
functional
groups.
Furthermore,
absence
surrogate
resulted
conservative
cases,
posing
practical
for
impurity
control.
Therefore,
new
framework
determining
recommended
was
urgently
needed.
Here,
Carcinogenic
Potency
Categorization
Approach
(CPCA)
its
supporting
scientific
rationale
presented.
The
CPCA
rapidly-applied
structure-activity
relationship-based
method
that
assigns
1
categories,
each
with
corresponding
limit,
reflecting
predicted
carcinogenic
potency.
considers
number
distribution
α-hydrogens
at
N-nitroso
center
other
activating
deactivating
affect
α-hydroxylation
metabolic
activation
pathway
carcinogenesis.
adopted
internationally
several
regulatory
authorities
simplified
starting
point
determine
nitrosamines
without
need
compound-specific
data.
Chemical Research in Toxicology,
Год журнала:
2024,
Номер
37(2), С. 181 - 198
Опубликована: Фев. 5, 2024
A
thorough
literature
review
was
undertaken
to
understand
how
the
pathways
of
N-nitrosamine
transformation
relate
mutagenic
potential
and
carcinogenic
potency
in
rodents.
Empirical
computational
evidence
indicates
that
a
common
radical
intermediate
is
created
by
CYP-mediated
hydrogen
abstraction
at
α-carbon;
it
responsible
for
both
activation,
leading
formation
DNA-reactive
diazonium
species,
deactivation
denitrosation.
There
are
competing
sites
CYP
metabolism
(e.g.,
β-carbon),
other
reactive
species
can
form
following
initial
bioactivation,
although
these
alternative
tend
decrease
rather
than
enhance
potency.
The
activation
pathway,
oxidative
dealkylation,
reaction
drug
carbonyl
byproduct,
e.g.,
formaldehyde,
does
not
contribute
toxic
properties
N-nitrosamines.
Nitric
oxide
(NO),
side
product
denitrosation,
similarly
be
discounted
as
an
enhancer
toxicity
based
on
carcinogenicity
data
substances
act
NO-donors.
However,
all
N-nitrosamines
potent
rodent
carcinogens.
In
significant
number
cases,
there
overlap
with
non-N-nitrosamine
carcinogens
Cohort
Concern
(CoC;
high-potency
comprising
aflatoxin-like-,
N-nitroso-,
alkyl-azoxy
compounds),
while
devoid
potential.
this
context,
mutagenicity
useful
surrogate
carcinogenicity,
proposed
ICH
M7
(R2)
(2023)
guidance.
Thus,
safety
assessment
control
medicines,
important
those
complementary
attributes
mechanisms
structure–activity
relationships
translate
elevated
versus
which
associated
reduction
in,
or
absence
of,
Journal of Agriculture and Food Research,
Год журнала:
2023,
Номер
13, С. 100645 - 100645
Опубликована: Май 24, 2023
Nitrite
and
nitrate
have
been
widely
used
in
the
preservation
of
meat
products
for
effective
antimicrobial
action
against
several
pathogenic
bacteria
such
as
Clostridium
botulinum,
Salmonella
mesophilic
bacteria.
However,
they
can
further
react
with
secondary
amines
produce
noxious
compounds
called
nitrosamines
during
thermal
processing.
N-nitrosamines
are
divided
into
volatile
non-volatile
N-nitrosamines,
among
which
a
group
highly
hazardous
chemical
carcinogens
whose
carcinogenicity
teratogenicity
led
to
widespread
concern.
Owing
their
occurrence
daily
diet,
it
is
great
significance
suppress
formation
toxicity
on
human
health
without
causing
adverse
effects
food
flavors.
In
this
paper,
mechanism
provided.
Potential
mitigations
be
carried
out
from
perspectives
precursors
raw
materials,
processing
conditions
well
exogenous
additives.
Moreover,
promoting
degradation
an
approach.
The
potential
risks
associated
described.
Different
intervention
substances,
polyphenols,
vitamins
various
plant
extracts
summarized,
discussing
impact
nitrosamines.
purpose
review
provide
theoretical
guidance
control
generation
deleterious
effects,
so
promote
development
practical
production.
Organic Process Research & Development,
Год журнала:
2023,
Номер
27(10), С. 1719 - 1735
Опубликована: Июль 26, 2023
The
onset
of
the
N-nitrosamine
(NA)
saga
in
2018
was
chiefly
related
to
certain
small
dialkyl
N-nitrosamines
originating
from
synthesis
active
pharmaceutical
ingredient
(API).
However,
subsequent
comprehensive
assessments
performed
on
APIs,
formulated
drug
products,
and
packaging
put
a
different
type
NAs
limelight:
diverse
range
complex
so-called
nitrosamine
drug-substance-related
impurities
(NDSRIs).
They
may
form
due
presence
potentially
nitrosatable
secondary
or
tertiary
amine
moieties
APIs
API
nitrosating
agents
formed
low
levels
nitrite
present
as
impurities.
unique
properties
functional
group
make
it
irreplaceable
APIs.
While
be
reduced,
formation
products
cannot
completely
prevented,
class
default
acceptable
intake
(AI)
18
ng/day
currently
poses
significant
challenges
terms
both
viable
control
analysis
at
such
levels.
Even
so,
NA
exposure
through
pharmaceuticals
is
expected
orders
magnitude
lower
than
via
food
endogenous
formation.
robust
carcinogenicity
data
are
available
for
many
small,
simple
NAs,
there
distinct
absence
most
NDSRIs.
Many
working
groups
have
therefore
been
established
share
rapidly
improve
knowledge
(whether
toxicity
data,
structure–activity
relationships,
analytical
techniques),
define
best
practices
assess
genotoxic
potential
NDSRIs,
advance
methods
calculate
AIs
based
solid
scientific
rationales.
Ultimately,
protect
patients
true
cancer
risk
secure
access
important
medicines,
crucial
manufacturers
health
authorities
pursue
efforts
implement
strategies
that
equally
effective
realistic.
As
patient
safety
paramount,
industry
committed
ensuring
medicines
supplies
safe
effective.
Where
legitimate
concerns
exist,
undisputed
appropriate
actions
must
taken,
which
could
include
withdrawal
market.
Chemical Research in Toxicology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 6, 2025
N-Nitrosamine
compounds
in
pharmaceuticals
are
a
major
concern
due
to
their
carcinogenic
potential.
However,
not
all
nitrosamines
strong
carcinogens,
and
understanding
the
structure-activity
relationships
of
this
compound
group
is
challenge.
The
determination
acceptable
intake
limits
for
determined
by
applying
either
simple
potency
categorization
approach
(CPCA)
or
read-across
analysis
from
where
experimental
data
exist.
emergence
structurally
complex
makes
quantitative
models
desirable.
Here,
we
present
two-step
modeling
based
on
linear
discriminant
set
quantum
mechanical
classical
descriptors
followed
3D-QSAR
PLS
regression
model
predict
logTD50
nitrosamine
compounds.
Regulatory Toxicology and Pharmacology,
Год журнала:
2023,
Номер
142, С. 105415 - 105415
Опубликована: Май 29, 2023
Low
levels
of
N-nitrosamines
(NAs)
were
detected
in
pharmaceuticals
and,
as
a
result,
health
authorities
(HAs)
have
published
acceptable
intakes
(AIs)
to
limit
potential
carcinogenic
risk.
The
rationales
behind
the
AIs
not
been
provided
understand
process
for
selecting
TD50
or
read-across
analog.
In
this
manuscript
we
evaluated
toxicity
data
eleven
common
NAs
comprehensive
and
transparent
consistent
with
ICH
M7.
This
evaluation
included
substances
which
had
datasets
that
robust,
limited
but
sufficient,
insufficient
experimental
animal
carcinogenicity
data.
case
robust
sufficient
information,
calculated
based
on
derived
TD50s
from
most
sensitive
organ
site.
available
structure
activity
relationships
(SARs)
applied
categorical-based
1500
ng/day,
150
ng/day
18
ng/day;
however
additional
(such
biological
computational
modelling)
could
inform
an
alternative
AI.
approach
advances
methodology
used
derive
NAs.
Chemical Research in Toxicology,
Год журнала:
2023,
Номер
36(2), С. 291 - 304
Опубликована: Фев. 6, 2023
N-Nitroso
contaminants
in
medicinal
products
are
of
concern
due
to
their
high
carcinogenic
potency;
however,
not
all
these
compounds
created
equal,
and
some
relatively
benign
chemicals.
Understanding
the
structure-activity
relationships
(SARs)
that
drive
hazards
one
molecule
versus
another
is
key
both
protecting
human
health
alleviating
costly
sometimes
inaccurate
animal
testing.
Here,
we
report
on
an
extension
CADRE
(computer-aided
discovery
REdesign)
platform,
which
used
broadly
by
pharmaceutical
personal
care
industries
assess
environmental
endpoints,
predict
potency
N-nitroso
compounds.
The
model
distinguishes
three
categories
with
77%
accuracy
external
testing,
surpasses
reproducibility
rodent
cancer
bioassays
constraints
imposed
limited
(high-quality)
data.
robustness
predictions
for
more
complex
pharmaceuticals
maximized
capturing
SARs
using
quantum
mechanics,
is,
hinging
underlying
chemistry
chemicals
training
set.
To
this
end,
present
approach
can
be
leveraged
a
quantitative
hazard
assessment
offer
qualitative
guidance
electronic
structure
comparisons
between
well-studied
analogues
unknown
contaminants.
Organic Process Research & Development,
Год журнала:
2023,
Номер
27(10), С. 1703 - 1713
Опубликована: Март 14, 2023
The
definitions
of
the
chemical
classes
in
Cohort
Concern
(CoC)
by
Kroes
and
co-workers
are
based
on
broad
structural
alerts,
particular
for
N-nitroso
compounds─for
which
alert
consists
essentially
N–N═O
substructure
without
further
refinement.
Recent
pharmaceutical
recalls
have
focused
presence
dialkyl
N-nitrosamine
impurities,
some
exceptionally
potent
carcinogens─2
orders
magnitude
more
than
Threshold
Toxicological
(TTC),
1.5
μg/day.
However,
class
"N-nitroso
compounds"
is
potentially
significantly
broader.
This
Perspective
looks
at
compounds
that
edges
cohort,
where
changes
mechanism,
metabolic
activation
potential,
stability,
or
indeed
toxicity
data
lead
to
questions
about
whether
these
should
be
classed
as
CoC.
critical
mechanism
action,
α-hydroxylation
leading
a
diazonium
ion,
presented,
along
with
pathways
not
N-nitrosamines
can
comparable
DNA
adducts.